Pharsight

Zoladex patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7500964 TERSERA Automatically operable safety shield system for syringes
Feb, 2021

(3 years ago)

US7220247 TERSERA Automatically operable safety shield system for syringes
Apr, 2022

(2 years ago)

US7118552 TERSERA Automatically operable safety shield system for syringes
Apr, 2022

(2 years ago)

Zoladex is owned by Tersera.

Zoladex contains Goserelin Acetate.

Zoladex has a total of 3 drug patents out of which 3 drug patents have expired.

Expired drug patents of Zoladex are:

  • US7500964
  • US7220247
  • US7118552

Zoladex was authorised for market use on 11 January, 1996.

Zoladex is available in implant;implantation dosage forms.

The generics of Zoladex are possible to be released after 13 April, 2022.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using GOSERELIN ACETATE ingredient

Market Authorisation Date: 11 January, 1996

Treatment: NA

Dosage: IMPLANT;IMPLANTATION

More Information on Dosage

ZOLADEX family patents

Family Patents